

![]() |
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 |
|
Authors | ![]() | |
Published in | European journal of clinical investigation. 2021, vol. 51, no. 11, e13661 | |
Abstract | Unravelling autoimmune targets triggered by SARS-CoV-2 infection may provide crucial insights into the physiopathology of the disease and foster the development of potential therapeutic candidate targets and prognostic tools. We aimed at determining (a) the association between anti-SARS-CoV-2 and anti-apoA-1 humoral response and (b) the degree of linear homology between SARS-CoV-2, apoA-1 and Toll-like receptor 2 (TLR2) epitopes. | |
Identifiers | DOI: 10.1111/eci.13661 PMID: 34324704 | |
Full text | ||
Structures |
Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences |
|
Research groups | Centre de vaccinologie et d'immunologie néonatale (177) Chimie et protéomique clinique (270) Emerging viruses (993) Groupe Laurent Kaiser (virologie clinique) (668) Groupe Pugin Jérôme (Soins intensifs) (587) Groupe Winssinger Hiv (835) Médecine de 1er recours (1020) | |
Citation (ISO format) | PAGANO, Sabrina et al. SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1. In: European Journal of Clinical Investigation, 2021, vol. 51, n° 11, p. e13661. doi: 10.1111/eci.13661 https://archive-ouverte.unige.ch/unige:154508 |